Daybreak is a custom-fitted mandibular advancement device for treating mild to moderate obstructive sleep apnea. It operates through a fully virtual pathway: an at-home sleep test, remote dental impressions, a board-certified physician review, and a custom device shipped directly to the patient’s door.
A peer-reviewed Cedars-Sinai study of 185 patients found a mean AHI reduction of 63.3% for mild OSA and 60.95% for moderate OSA. Overall, 83% of patients met the Sleep Health Experts Recommendations (SHER) criteria for treatment success. The device is FDA cleared, covered by most major insurance plans, and requires zero clinic appointments from start to finish.
This review covers how Daybreak works, what real users and the FDA malfunction database report, what the side effects are, and whether the price is justified for mild to moderate OSA. Every key question is answered below with sourced clinical data before you commit to a treatment path.
What Is Daybreak Sleep Apnea Treatment?
Daybreak is a custom-fitted mandibular advancement device (MAD) for treating obstructive sleep apnea and snoring. It’s dispensed through a fully virtual, dentist-directed care pathway. No clinic visits required.
Here’s the thing: obstructive sleep apnea affects an estimated 54 million people in the U.S. It causes repeated episodes of upper airway obstruction during sleep. Untreated, it raises the risk of cardiovascular disease, cognitive impairment, and reduced quality of life.
The Daybreak model combines an at-home sleep test, remote dental impressions, and custom device fabrication. Patients receive the finished appliance by mail and complete titration guidance virtually. Bottom line: you don’t need to leave home.
Who Is Daybreak Designed For?
Daybreak targets adults with mild to moderate obstructive sleep apnea who want a CPAP-free treatment path. The American Academy of Sleep Medicine (AASM) classifies MADs as a first-line option for mild OSA and a strong CPAP alternative for moderate OSA.
The device is also appropriate for diagnosed patients who can’t tolerate a CPAP mask. Those who travel frequently benefit from its compact, portable design compared to bulkier CPAP equipment.
Daybreak is not intended for severe OSA or for patients without a formal diagnosis. The company requires either a new home sleep test or documentation of an existing diagnosis before dispensing the device.
How Does the Daybreak Device Work?
The Daybreak device repositions the lower jaw forward during sleep, which mechanically widens the upper airway and prevents collapse. This reduces both apnea events and snoring by maintaining airway patency throughout the night.
The process starts with a WatchPAT home sleep apnea test. It’s an FDA-cleared finger-worn device that measures breathing patterns during two nights of normal sleep. Results are reviewed by a board-certified physician within 24 hours of submission.
If sleep apnea is confirmed, the patient takes dental impressions at home using a kit from Daybreak. The laboratory fabricates a custom MAD and ships it directly. Titration begins at 1 mm of jaw advancement and increases in 1 mm weekly increments until symptoms resolve.
Daybreak Treatment Steps:
- Order and complete the WatchPAT at-home sleep test for two nights.
- Receive a physician-reviewed diagnosis within 24 hours of returning the device.
- Take dental impressions at home using the Daybreak impression kit.
- Receive the custom-fabricated MAD by mail within the agreed turnaround time.
- Begin titration at 1 mm jaw advancement and increase weekly until symptoms resolve.
- Complete a post-treatment home sleep test to confirm AHI reduction.
What Are the Components of the Daybreak Device?
Daybreak consists of a custom-molded upper and lower tray linked by a calibrated advancement mechanism that holds the jaw forward at a prescribed position. Unlike over-the-counter boil-and-bite mouthpieces, the appliance is fabricated from impressions of the patient’s actual teeth.
The WatchPAT home sleep test is a three-point wearable device. It includes a chest sensor, a wrist bracelet worn on the non-dominant hand, and a finger probe. Together, these sensors record oxygenation levels, breathing patterns, and sleep stage data.
The dental impression kit includes putty trays used to capture a precise bite map. Daybreak’s clinical team reviews the impressions before fabrication. The final device is made in the USA and ships with a 3-year warranty on the hardware.
Daybreak Package Includes:
- WatchPAT FDA-cleared home sleep test kit
- At-home dental impression kit with putty trays
- Custom-fabricated mandibular advancement device (USA-made)
- Board-certified physician diagnosis and prescription
- Virtual titration support and follow-up sleep test
- 3-year device warranty and patient care guarantee
Is the Daybreak Device FDA Cleared?
Yes. The Daybreak device holds FDA clearance for treating obstructive sleep apnea and snoring in adults. The WatchPAT home sleep test used for diagnosis is also independently FDA cleared.
FDA clearance means the device has passed the agency’s 510(k) pathway. That demonstrates safety and substantial equivalence to previously cleared predicate devices. In plain English: it’s been reviewed and approved to do exactly what it claims.
The American Academy of Dental Sleep Medicine (AADSM) endorses MADs as an established OSA treatment with over 30 years of clinical history. Daybreak’s clinical pathway is directed by licensed dentists and physicians, not by self-service algorithms.
What Are the Benefits of Daybreak for Sleep Apnea?
Daybreak delivers a fully at-home pathway from diagnosis to treatment. In-person sleep lab visits and dental clinic appointments are not required. Patients receive a doctor-reviewed diagnosis, a custom device, and ongoing titration support without leaving home.
The device is compact and portable compared to CPAP equipment. It requires no mask, no hose, and no electrical power source. And here’s what that means for travelers: it fits in a carry-on bag and works anywhere.
Insurance coverage is available for most patients. The company is FSA eligible and handles insurance processing on behalf of patients, which reduces the administrative burden of reimbursement claims substantially.
Does Daybreak Actually Reduce Sleep Apnea Events?
Yes. Daybreak achieved a mean apnea-hypopnea index (AHI) reduction of 63.3% in mild OSA patients and 60.95% in moderate OSA patients in a peer-reviewed study. The research was conducted by investigators at Cedars-Sinai Medical Center and published in the American Journal of Clinical and Medical Research.
The study evaluated 185 patients using Daybreak’s telehealth-guided MAD pathway. For mild OSA, AHI dropped from 9.08 to 3.33. For moderate OSA, AHI fell from 22 to 8.59. Overall, 83% of patients met the Sleep Health Experts Recommendations (SHER) criteria for treatment success.
Here’s what that means: among mild OSA patients, 88% achieved a post-treatment AHI below 5, and 95% achieved an AHI below 10. For moderate OSA patients, 48% reached an AHI below 5, and 77% reached an AHI below 10. In addition, 82% of all patients reported subjective improvement in snoring.
AHI Outcomes by OSA Severity:
| OSA Severity | Baseline AHI | Post-Treatment AHI | AHI Reduction |
| Mild OSA | 9.08 | 3.33 | 63.3% |
| Moderate OSA | 22.0 | 8.59 | 60.95% |
Does Daybreak Work Better Than CPAP?
Daybreak achieves comparable AHI reductions to traditional in-clinic MAD therapy and outperforms CPAP on adherence for patients who can’t tolerate mask-based treatment. The Cedars-Sinai study found outcomes ‘comparable to traditional care models’ using a fully virtual approach.
CPAP remains the gold standard for severe OSA. That’s because it can abolish apnea events in virtually all patients when used correctly. For mild to moderate OSA, however, MADs often outperform CPAP on real-world adherence because patients find them more comfortable to wear through the night.
The AASM and AADSM jointly recommend MADs as a first-line option for mild OSA and a strong alternative for moderate OSA. This is especially true when CPAP is refused or poorly tolerated. Daybreak’s virtual model expands access to this established therapy without clinic visits.
Daybreak vs. CPAP Comparison:
| Feature | Daybreak MAD | CPAP |
| Mask required | No | Yes |
| Power source needed | No | Yes |
| Travel friendly | Yes | Limited |
| Best for severe OSA | No | Yes |
| Insurance coverage | Most plans | Most plans |
| At-home setup | Yes | Partial |
What Do Daybreak Reviews Say?
Daybreak receives consistently positive feedback for its comfort, customer support, and the speed of the diagnostic process. The at-home model appeals to users who’ve previously avoided traditional sleep labs due to cost or inconvenience.
Critical reviews focus on the length of the fitting process, price, and isolated cases where the device didn’t produce expected AHI reductions. The FDA’s medical device database contains a small number of malfunction reports from patients whose independent sleep tests showed residual apnea after treatment.
So what’s the overall picture? The majority of published user experiences describe meaningful improvement in sleep quality, daytime alertness, and snoring. The support team receives frequent praise, with individual staff members cited by name for their responsiveness.
What Do Positive Reviewers Report?
Positive Daybreak reviewers consistently report improved sleep quality, elimination of CPAP equipment, and relief from snoring within weeks of starting treatment. Multiple customers describe the device as comfortable enough to forget it’s in the mouth during sleep.
One verified reviewer stated that Daybreak ‘ended my sleep apnea symptoms immediately’ and that the process was ‘simple, elegant and non-invasive.’ Another reported that the home sleep test ‘accurately showed my sleep apnea events, REM cycle timing, and oxygenation’ with results arriving within 24 hours.
Bed partners benefit too. One reviewer noted that after their wife began using Daybreak, ‘she sleeps peacefully and doesn’t have the big health risks of sleep apnea’ — and the reviewer slept better because the snoring had stopped.
Key Positives Reported by Customers:
- Sleep quality improved significantly within the first month of use
- At-home diagnosis process completed without clinic visits
- Representative support described as knowledgeable and responsive
- Device described as comfortable and easy to travel with
- Snoring eliminated, with benefits reported by bed partners
What Are the Common Complaints About Daybreak?
The most common complaint about Daybreak is the length and complexity of the fitting process, which can span 3 to 4 months from first contact to a correctly calibrated device. Some users report receiving an ill-fitting appliance before the final version was produced.
Price is another recurring concern. The device costs approximately $1,800 out of pocket without insurance reimbursement. At least one FDA malfunction report describes a patient who paid $1,800 and whose independent post-treatment sleep study showed an AHI of 11.3, compared to a baseline of 13.0. That’s minimal clinical benefit for the cost.
And here’s the part most people miss: refund disputes have also been documented. Daybreak’s patient care guarantee offers refunds within a 90-day window, but some patients report that delays in receiving a working device extended beyond that window. Those patients became ineligible for a refund despite unresolved treatment outcomes.
Common Complaints by Category:
- Fitting process takes 3 to 4 months to complete
- High out-of-pocket cost if insurance does not cover the device
- Isolated cases of device not reducing AHI to therapeutic levels
- Refund window may close before device is fully calibrated
- Insurance reimbursement follow-up not always completed as promised
What Are the Side Effects of Daybreak?
Daybreak carries side effects typical of mandibular advancement devices, including temporary jaw soreness, tooth sensitivity, and increased salivation during the adjustment period. These effects are most common in the first 2 to 4 weeks of use as the jaw adapts to its new resting position.
Dental sleep medicine specialists note that MAD titration involves small incremental adjustments, typically 1 mm at a time. Advancing the jaw too quickly increases the likelihood of temporomandibular joint (TMJ) discomfort and muscle soreness. Daybreak’s weekly titration protocol is designed to minimize this risk.
Long-term use of MADs can, in some cases, produce minor tooth movement or changes in bite alignment. To be clear: periodic dental check-ups during treatment help monitor for these changes. The patient care guarantee covers refunds under certain conditions related to adverse effects.
Do MADs Like Daybreak Cause Jaw or Tooth Problems?
MADs can cause jaw soreness and minor bite changes, but serious TMJ damage is uncommon when devices are properly titrated and monitored. Clinical evidence and specialist guidance indicate that cautious, incremental titration reduces the risk of significant musculoskeletal side effects.
Dr. Martin L. Hopp, MD, PhD, a co-investigator in the Cedars-Sinai Daybreak study, notes that bringing the jaw forward by 3 to 4 mm (0.12 to 0.16 inches) is typically sufficient to open the airway for most patients. Advancing beyond what’s clinically necessary increases joint strain without additional benefit.
Daybreak instructs patients to rinse the device thoroughly and maintain regular dental hygiene. The reason is simple: saliva flow around the appliance creates conditions that can increase the risk of dental problems if oral care is neglected. Keeping the device clean reduces this risk substantially.
Is Daybreak Legit or a Scam?
Yes. Daybreak is a legitimate FDA-cleared medical device company operating under a dentist-directed virtual care model supported by peer-reviewed clinical research. The company’s device and diagnostic pathway are both independently cleared by the FDA.
A peer-reviewed study published in the American Journal of Clinical and Medical Research evaluated 185 patients and found statistically significant AHI reductions with Daybreak’s virtual MAD therapy. The research was conducted at Cedars-Sinai Medical Center, one of the most respected academic medical centers in the United States.
In fact, the company handles insurance processing directly, which is a service typically offered only by established healthcare providers. Complaint patterns in the FDA device database are consistent with known challenges in MAD therapy, not with fraudulent product design.
Is Daybreak Covered by Insurance?
Yes. Daybreak is covered by most major insurance plans as a durable medical device for obstructive sleep apnea, and the company handles insurance processing on the patient’s behalf. The device is also FSA and HSA eligible for patients who use pre-tax health accounts.
Coverage eligibility typically requires a formal OSA diagnosis with an AHI that meets the insurer’s clinical threshold. Daybreak’s at-home sleep test, reviewed by a board-certified physician, generates the diagnostic documentation needed to support an insurance claim.
Medicare coverage for MADs is available under durable medical equipment benefits for eligible beneficiaries. Patients should verify their specific plan’s requirements before assuming full coverage, as deductibles, copays, and in-network requirements vary by plan.
How Much Does Daybreak Cost?
Daybreak costs approximately $1,800 out of pocket for the full diagnosis and device package, though insurance coverage can reduce this substantially for eligible patients. The at-home sleep test is available separately at a reduced rate for patients who need diagnosis only.
The company has promoted the sleep test at under $60 through limited-time discount codes on its social media channels. The full device package includes the custom appliance, titration support, follow-up sleep testing, and a 3-year warranty on the device hardware.
A 60-day money-back guarantee applies to the device under specified conditions. Read the patient care guarantee terms carefully before purchasing — particularly the refund window and what constitutes a qualifying return.
Is Daybreak Worth the Price?
Daybreak offers strong clinical value for mild to moderate OSA patients who qualify for insurance coverage, as the net out-of-pocket cost can be comparable to standard in-clinic MAD therapy. For patients without coverage, the $1,800 price point requires careful consideration.
The good news? The cost of untreated sleep apnea is substantial. Researchers have estimated that OSA imposes billions of dollars annually in healthcare costs, lost productivity, and accident risk. Effective treatment that produces an 83% success rate, as demonstrated in the Cedars-Sinai study, offsets those downstream costs.
Over-the-counter anti-snoring mouthpieces cost significantly less, but they’re not intended to treat OSA. Patients with a confirmed OSA diagnosis require a device designed to meet clinical efficacy standards. That’s what Daybreak provides.
Where Can You Buy Daybreak?
Daybreak is available exclusively through the company’s official website at thedaybreak.com, where patients initiate the diagnostic process and order the at-home sleep test. The device is not available through retail pharmacies or third-party e-commerce platforms.
Daybreak also partners with a network of durable medical equipment (DME) suppliers, including Barber DME Supply Group, which provides Daybreak devices with nationwide service. Patients whose physicians have already prescribed the device can access it through these DME channels as well.
The company advises against purchasing Daybreak through unauthorized resellers. The custom fit requires direct dental impression review by Daybreak’s clinical team. A device made from impressions not reviewed by licensed professionals can’t be properly calibrated or guaranteed.
Is Daybreak Available Through Insurance Suppliers?
Yes. Daybreak works with a network of durable medical equipment suppliers who can fulfill the device for patients with insurance prescriptions. Barber DME Supply Group is one confirmed nationwide partner that handles Daybreak orders with insurance processing support.
Patients who receive a Daybreak prescription through their primary physician can route the order through a DME supplier rather than the company’s direct website. This pathway is common for Medicare and Medicaid beneficiaries whose coverage is tied to specific DME networks.
The company advises verifying that the DME supplier is authorized to dispense Daybreak devices. Unauthorized resellers cannot access the clinical oversight or titration support that the official pathway provides.
Is Daybreak Worth It for Sleep Apnea?
Who Should Consider Alternatives to Daybreak?
Patients with severe OSA require CPAP therapy or surgical evaluation rather than a mandibular advancement device, because MADs do not achieve sufficient AHI control at that severity level. Daybreak’s FDA clearance and clinical data apply to mild and moderate OSA only.
Patients who have previously failed MAD therapy — whether due to jaw discomfort, bite changes, or insufficient AHI reduction — may benefit from in-person evaluation at a dental sleep medicine clinic. A specialist can assess jaw anatomy and titration history before recommending a second MAD attempt.
Those who need an immediate treatment solution also face a challenge with Daybreak. The median time to treatment completion is 42 days, and some users report 3 to 4 months of fitting adjustments. Patients with urgent clinical needs may require a faster clinical pathway.
Daybreak is a clinically sound choice for mild to moderate OSA patients who want a CPAP alternative, provided they’re covered by insurance and prepared for a multi-week fitting process. The peer-reviewed AHI reduction data from Cedars-Sinai places it among the better-documented virtual MAD programs available.
Think of it this way: the fully at-home model removes a genuine barrier to care. Many people with OSA go undiagnosed or untreated because traditional pathways involve sleep lab appointments, specialist wait times, and multiple clinic visits. Daybreak compresses that process into a mail-in workflow most patients complete in under 6 weeks.
Patients with severe OSA, those who’ve failed MAD therapy before, or those who need immediate symptom control may be better served by in-person clinical evaluation. For everyone else, Daybreak represents a well-supported, FDA-cleared path to treating a condition that affects tens of millions of people who currently go without adequate care.